1Troughton RW, Frampton CM, Yahdle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide concentrations [ J ]. Lancet, 2000,355 ( 9210 ) : 1126 - 1130.
2Morrow DA, Delemons JA, Sabatine MS, et al. Evaluation of B- type natriuretic peptide for risk assessment in unstable angina/non- ST- elevation myocardial infarctions B- type natriuretic peptide and prognosis in TACTICS TIMI 18[J]. J Am Coil Cardiol,2003,41(8) : 1264 - 1272.
3Mairj, Friedc W, Thomass, et al. Natriuretic peptides in assessment of left ventricular dysfunction scanal olin lab Tnvest suppl. 1999,230,132 - 142.
4Arakawa N, Nakamura M, Aoki H, et al. Relationship between plasma level ofbrain natruretic peptide andmyocardial infarct size[J]. Cardiology, 1994,85 (5): 334 - 340.
5Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B-type natriuretic peptide (BNP) testing[J]. Eur Heart, 2003,24(19) :1710 - 1718.
1Kleczyński P,Legutko J,Rakowski T,et al.Predictive utility of NT-pro BNP for infarct size and left ventricle function after acute myocardial infarction in long-term follow-up[J].Disease markers,2013,34(3):199-204.
